Taysha Gene Therapies, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.64
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
11
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.82
|
-0.64
|
0.18
|
21.95%
|
|
2022-06-30
|
-1.00
|
-0.84
|
0.16
|
16.00%
|
|
2022-03-31
|
-1.07
|
-1.31
|
-0.24
|
-22.43%
|
|
2021-12-31
|
-1.25
|
-1.32
|
-0.07
|
-5.60%
|
|
2021-09-30
|
-1.08
|
-1.35
|
-0.27
|
-25.00%
|
|
2021-06-30
|
-0.84
|
-1.09
|
-0.25
|
-29.76%
|
|
2021-03-31
|
-0.56
|
-0.87
|
-0.31
|
-55.36%
|
|
2020-12-31
|
-0.37
|
-1.04
|
-0.67
|
-181.08%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.79
|
|
2021-12-31
|
-4.63
|
|
2020-12-31
|
-3.60
|